Total Payments
$1,038
2021 Payments
$1,038
Companies
18
Transactions
62
Medicare Patients
1,004
Medicare Billing
$56,318
Payment Breakdown by Category
Food & Beverage$1,038 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,038 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $338.46 | 23 | $0 (2021) |
| Novo Nordisk Inc | $119.24 | 7 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $97.73 | 5 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $67.37 | 4 | $0 (2021) |
| Adlon Therapeutics L.P. | $65.41 | 3 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $58.77 | 3 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $52.60 | 2 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $43.40 | 3 | $0 (2021) |
| Amarin Pharma Inc. | $35.59 | 2 | $0 (2021) |
| Amgen Inc. | $25.84 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,038 | 62 | AbbVie Inc. ($338.46) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.41 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Virology & Specialty Care | ||||||
| 12/04/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: PRIMARY CARE | ||||||
| 11/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: DIABETES | ||||||
| 09/27/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Diabetes | ||||||
| 09/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiovascular | ||||||
| 09/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Diabetes | ||||||
| 08/26/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Central Nervous System | ||||||
| 08/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/16/2021 | Amgen Inc. | Aimovig (Biological), Otezla | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Neuroscience | ||||||
| 08/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY, TRIJARDY XR | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: DIABETES | ||||||
| 08/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 252 | 296 | $49,540 | $16,784 |
| 2022 | 4 | 264 | 292 | $45,310 | $16,820 |
| 2021 | 6 | 312 | 401 | $54,380 | $16,562 |
| 2020 | 5 | 176 | 203 | $30,275 | $6,151 |
Total Patients
1,004
Total Services
1,192
Medicare Billing
$56,318
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 171 | 209 | $32,395 | $10,932 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 72 | $16,920 | $5,801 | 34.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 15 | $225.00 | $51.15 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 175 | 200 | $31,000 | $12,165 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 54 | $12,690 | $4,400 | 34.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 21 | 21 | $1,365 | $196.61 | 14.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 17 | 17 | $255.00 | $58.39 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 117 | $27,470 | $6,263 | 22.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $7,480 | $5,280 | 70.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 79 | 99 | $15,325 | $3,452 | 22.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 13 | 13 | $1,105 | $848.38 | 76.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 22 | 22 | $880.00 | $400.40 | 45.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 78 | 106 | $2,120 | $318.00 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 64 | $15,015 | $3,412 | 22.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 75 | $11,545 | $1,918 | 16.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 27 | 29 | $2,755 | $522.03 | 18.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 13 | $520.00 | $233.02 | 44.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 19 | 22 | $440.00 | $65.94 | 15.0% |
About Ashley David
Ashley David is a Registered Nurse healthcare provider based in Downingtown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2016. The National Provider Identifier (NPI) number assigned to this provider is 1144777848.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley David has received a total of $1,038 in payments from pharmaceutical and medical device companies, with $1,038 received in 2021. These payments were reported across 62 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,038).
As a Medicare-enrolled provider, David has provided services to 1,004 Medicare beneficiaries, totaling 1,192 services with total Medicare billing of $56,318. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Student in an Organized Health Care Education/Training Program, Family
- Location Downingtown, PA
- Active Since 09/09/2016
- Last Updated 09/17/2024
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1144777848
Products in Payments
- VRAYLAR (Drug) $155.69
- UBRELVY (Drug) $114.79
- JARDIANCE (Drug) $97.73
- Ozempic (Drug) $91.05
- ADHANSIA XR (Drug) $65.41
- LINZESS (Drug) $62.65
- NURTEC ODT (Drug) $58.77
- AJOVY (Biological) $52.60
- BELSOMRA (Drug) $51.82
- Livalo (Drug) $43.40
- Vascepa (Drug) $35.59
- Aimovig (Biological) $25.84
- XARELTO (Drug) $23.63
- INJECTAFER (Drug) $23.40
- Strensiq (Drug) $20.48
- ZENPEP (Drug) $18.31
- Tobradex ST (Drug) $18.21
- JANUVIA (Drug) $15.55
- Wegovy (Drug) $14.84
- EMGALITY (Drug) $14.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.